Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Teva
US Army
Farmers Insurance
Moodys
Johnson and Johnson

Generated: August 24, 2019

DrugPatentWatch Database Preview

Litigation Details for Amgen Inc. v. Amneal Pharmaceuticals (D. Del. 2016)

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Amgen Inc. v. Amneal Pharmaceuticals (D. Del. 2016)

Docket ➤ Sign Up Date Filed 2016-09-22
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Gregory Moneta Sleet
Jury Demand None Referred To
Parties ACTAVIS PHARMA, INC.; AJANTA PHARMA LIMITED; AJANTA PHARMA USA INC.; AMGEN INC.; AMNEAL PHARMACEUTICALS LLC; AMNEAL PHARMACEUTICALS OF NEW YORK LLC; APOTEX CORP.; APOTEX INC.; AUROBINDO PHARMA LTD.; AUROBINDO PHARMA USA INC.; BRECKENRIDGE PHARMACEUTICAL INC.; CADILA HEALTHCARE LTD.; CIPLA LIMITED; CIPLA USA INC.; DR. REDDYS LABORATORIES, INC.; DR. REDDYS LABORATORIES, LTD.; HETERO LABS LTD.; HETERO LABS LTD. UNIT V; HETERO USA INC.; MICRO LABS LIMITED; MICRO LABS USA, INC.; MYLAN INC.; MYLAN PHARMACEUTICALS INC.; PIRAMAL HEALTHCARE LIMITED; STRIDES PHARMA GLOBAL PTE LIMITED; STRIDES PHARMA INC.; SUN PHARMA GLOBAL FZE; SUN PHARMACEUTICAL INDUSTRIES LTD.; SUN PHARMACEUTICAL INDUSTRIES, INC.; WATSON LABORATORIES, INC.; ZYDUS PHARMACEUTICALS (USA) INC.
Patents 6,211,244; 6,316,460; 9,375,405
Attorneys Aaron F. Barkoff; Alejandro Menchaca; Anil H. Patel; Arun John Mohan; Bindu Ann George Palapura; C. Kyle Musgrove; Caroline L. Marsili; Christopher B. Essig; David A. Bilson; David Ellis Moore; David M. Fry; Deepro R. Mukerjee; Derek S. Neilson; Dominick T. Gattuso; Elizabeth E. Grden; Elizabeth J. Weiskopf; Elizabeth M. Crompton; Gene A. Lang; George C. Lombardi; Iams J. Travis; Ian Scott; J. Clayton Athey; Jack B. Blumenfeld; Jaimin H. Shah; Jake M. Holdreith; James S. Green; Jared Thomas Green; John C. Phillips , Jr.; John K. Hsu; John W. Bateman; John W. Shaw; Joseph James Bellew; Joseph M. Bennett-Paris; Joseph M. Janusz; Joshua H. Lee; Karen Elizabeth Keller; Kaveh Saba; Kelsey J. Thorkelson; Kenneth Laurence Dorsney; Lance A Soderstrom; Marilyn Neiman; Mark S. Schuman; Martin B. Pavane; Mary Matterer; Maryellen Noreika; Oren D. Langer; Philip Y. Kouyoumdjian; Rajendra A. Chiplunkar; Samuel T. Lockner; Sara E. Bussiere; Stamatios Stamoulis; Stephanie M. Roberts; Stephen B. Brauerman; Steven A. Maddox; Tara L. Feld; William D. Hare; Zachary L. Sorman
Firms Bayard, P.A.; Heyman Enerio Gattuso & Hirzel LLP; Morris, Nichols, Arsht & Tunnell; Phillips, Goldman, McLaughlin & Hall, P.A.; Prickett, Jones & Elliott, P.A.; Schiff Hardin LLP; Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Amgen Inc. v. Amneal Pharmaceuticals
The small molecule drugs covered by the patents cited in this case are ➤ Sign Up and ➤ Sign Up .
Biologic Drugs cited in Amgen Inc. v. Amneal Pharmaceuticals
The biologic drug covered by the patents cited in this case is ➤ Sign Up .

Details for Amgen Inc. v. Amneal Pharmaceuticals (D. Del. 2016)

Date Filed Document No. Description Snippet Link To Document
2018-04-19 357 Defendants infringed United States Patent No. 9,375,405 (“the ’405 patent”) titled “Rapid Dissolution Formulation… 1. The ’405 Patent The ’405 patent issued from U.S. Patent Application No. 12/942,…OPINION This is a consolidated case for patent infringement brought by Plaintiff Amgen Inc. (…construed the meaning of the Markush groups in the ’405 patent; and (ii) Zydus’ Motion in Limine to preclude …case will be decided based on claim 1 of the ’405 patent, which states: (1) A pharmaceutical External link to document
2018-07-27 375 Opinion 2 through 24 as obvious “over Van Wagenen (US 6,211,244 B1) as evidenced by Kajiyama et al. (US 6,656,492…consolidated patent infringement action arising under the Drug Price Competition and Patent Term Restoration…Hatch-Waxman Act. United States Patent No. 9,375,405 (the “’405 patent”) is assigned to Plaintiff Amgen…BACKGROUND A. The ’405 Patent The ’405 patent, entitled “Rapid Dissolution Formulation… was issued by the United States Patent and Trademark Office (“Patent Office”) on June 28, 2016. (D.I External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Medtronic
Fuji
AstraZeneca
Julphar
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.